PLSCR1 knockdown significantly inhibited the proliferation, adhesion, migration and invasion of cancer cells, suggesting that PLSCR1 might be a suitable therapeutic target in regimens aimed at preventing the progression of primary liver cancers [81]. This evidence concerns the gene PLSCR1 and liver cancer.